Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 25,394 |
|
|||||
| News | - | ||||||
| Day High | 0.678 | Low High |
|||||
| Day Low | 0.6216 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Monopar Therapeutics Inc | MNPR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.028 | -4.13% | 0.65 | 14:21:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.678 | 0.6216 | 0.678 | 0.678 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 115 | 25,394 | $ 0.6534465 | $ 16,594 | - | 0.2739 - 1.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:32:21 | 21 | $ 0.65 | USD |
Monopar Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.51M | 14.87M | - | 0 | -8.4M | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Monopar Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MNPR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.80 | 0.82 | 0.6216 | 0.7315155 | 154,843 | -0.15 | -18.75% |
| 1 Month | 0.70 | 0.85 | 0.4999 | 0.6981385 | 197,148 | -0.05 | -7.14% |
| 3 Months | 0.3545 | 1.73 | 0.309 | 1.01 | 5,864,523 | 0.2955 | 83.36% |
| 6 Months | 0.49 | 1.73 | 0.2739 | 0.9264461 | 3,266,281 | 0.16 | 32.65% |
| 1 Year | 1.28 | 1.75 | 0.2739 | 0.9287994 | 1,768,626 | -0.63 | -49.22% |
| 3 Years | 5.30 | 6.98 | 0.2739 | 1.03 | 603,560 | -4.65 | -87.74% |
| 5 Years | 24.14 | 48.00 | 0.2739 | 1.63 | 449,074 | -23.49 | -97.31% |
Monopar Therapeutics Description
| Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. |
